{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:53:36Z","timestamp":1761580416715},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,2,1]],"date-time":"2007-02-01T00:00:00Z","timestamp":1170288000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2007,2]]},"DOI":"10.1016\/j.ijantimicag.2006.02.017","type":"journal-article","created":{"date-parts":[[2006,7,6]],"date-time":"2006-07-06T23:08:06Z","timestamp":1152227286000},"page":"145-152","source":"Crossref","is-referenced-by-count":7,"title":["In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data"],"prefix":"10.1016","volume":"29","author":[{"given":"Min-Nan","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hou-Tai","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Sen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yuan","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ing-Shen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jen-Hsien","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen-Fu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jainn-Ming","family":"Shyr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Chien","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiunn-Jong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Ching","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Kuei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lee-Jene","family":"Teng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwen-Tay","family":"Luh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 1","key":"10.1016\/j.ijantimicag.2006.02.017_bib1","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1093\/clinids\/24.Supplement_1.S19","article-title":"Evolution and dissemination of beta-lactamases accelerated by generations of beta-lactam antibiotics","volume":"24","author":"Medeiros","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1128\/CMR.1.1.109","article-title":"Beta-lactamase inhibitors from laboratory to clinic","volume":"1","author":"Bush","year":"1988","journal-title":"J Clin Microbiol"},{"issue":"Suppl. 7","key":"10.1016\/j.ijantimicag.2006.02.017_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003495-198800357-00005","article-title":"In vitro evaluations of aminopenicillin\/beta-lactamase inhibitor combinations","volume":"35","author":"Jones","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib4","doi-asserted-by":"crossref","unstructured":"Campoli-Richards DM, Brogden RN. Sulbactam\/ampicillin. A review of its antibacterial activity, pharmacokinetic properties, and therapeutic use. Drugs 1987;33:577\u2013609. [Erratum. Drugs 1987;35:515.]","DOI":"10.2165\/00003495-198733060-00003"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/00365540510026869","article-title":"Treatment of pan-drug resistant Acinetobacter baumannii","volume":"37","author":"Lee","year":"2005","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib6","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/j.1469-0691.1998.tb00039.x","article-title":"Bactericidal activity of three beta-lactams alone or in combination with a beta-lactamase inhibitor and two aminoglycosides against Klebsiella pneumoniae harboring extended-spectrum beta-lactamases","volume":"4","author":"Roussel-Delvallez","year":"1998","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0924-8579(00)00329-0","article-title":"The in vitro activity of sulbactam combined with third generation cephalosporins against third generation cephalosporin-resistant bacteria","volume":"17","author":"Zhang","year":"2001","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib8","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1128\/AAC.10.4.736","article-title":"Susceptibility of anaerobic bacteria to 23 antimicrobial agents","volume":"10","author":"Sutter","year":"1976","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib9","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1046\/j.1469-0691.2003.00786.x","article-title":"Comparative in vitro activity of piperacillin, piperacillin\u2013sulbactam and piperacillin\u2013tazobactam against nosocomial pathogens isolated from intensive care patients","volume":"9","author":"Frank","year":"2003","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1128\/AAC.48.5.1586-1592.2004","article-title":"In vitro activities of the beta-lactamase inhibitors clavulanic acid, sulbactam, and tazobactam alone or in combination with beta-lactams against epidemiologically characterized multidrug-resistant Acinetobacter baumannii strains","volume":"48","author":"Higgins","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib11","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.ijantimicag.2003.10.008","article-title":"In vitro activities of beta-lactam antibiotics alone and in combination with sulbactam against Gram-negative bacteria","volume":"23","author":"Wang","year":"2004","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijantimicag.2005.02.018","article-title":"Piperacillin\u2013sulbactam versus piperacillin\u2013tazobactam: a multicentre, randomised, single-blind, controlled clinical trial","volume":"26","author":"Zong","year":"2005","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib13","series-title":"Performance standards for antimicrobial susceptibility testing: Twelfth Informational Supplement. M100-S15","year":"2005"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib14","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1128\/AAC.34.1.156","article-title":"Diverse potential of beta-lactamase inhibitors to induce class I enzymes","volume":"34","author":"Weber","year":"1990","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib15","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1093\/jac\/dkh080","article-title":"In vitro and in vivo activity of meropenem and sulbactam against a multidrug-resistant Acinetobacter baumannii strain","volume":"53","author":"Ko","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib16","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1128\/JCM.36.11.3415-3416.1998","article-title":"In vitro activities of ampicillin\u2013sulbactam and amoxicillin\u2013clavulanic acid against Acinetobacter baumannii","volume":"36","author":"Pandey","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib17","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/clinids\/24.3.494","article-title":"Beta-lactamase inhibition and in vitro activity of sulbactam and sulbactam\/cefoperazone","volume":"24","author":"Williams","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1128\/AAC.38.4.767","article-title":"Comparative activities of clavulanic acid, sulbactam, and tazobactam against clinically important beta-lactamases","volume":"38","author":"Payne","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1007\/s005200000225","article-title":"Piperacillin, beta-lactam inhibitor plus gentamicin as empirical therapy of a sequential regimen in febrile neutropenia of pediatric cancer patients","volume":"9","author":"Fleischhack","year":"2001","journal-title":"Support Care Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.ijantimicag.2006.02.017_bib20","first-page":"S503","article-title":"Pharmacokinetics of sulbactam\/ampicillin in humans: a review","volume":"8","author":"Foulds","year":"1986","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib21","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/0732-8893(89)90084-9","article-title":"Studies to optimize the in vitro testing of piperacillin combined with tazobactam (YTR 830)","volume":"12","author":"Jones","year":"1989","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib22","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1128\/JCM.36.5.1361-1365.1998","article-title":"Effects of following National Committee for Clinical Laboratory Standards and Deutsche Industrie Norm-Medizinische Mikrobiologie guidelines, country of isolate origin, and site of infection on susceptibility of Escherichia coli to amoxicillin\u2013clavulanate (Augmentin)","volume":"36","author":"Simpson","year":"1998","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib23","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1128\/AAC.39.11.2591","article-title":"Susceptibility testing with clavulanic acid: fixed concentration versus fixed ratio","volume":"39","author":"Thomson","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. A","key":"10.1016\/j.ijantimicag.2006.02.017_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1093\/jac\/31.suppl_A.39","article-title":"The chemistry, pharmacokinetics and tissue distribution of piperacillin\/tazobactam","volume":"31","author":"Sorgel","year":"1993","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib25","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/AAC.41.4.721","article-title":"Importance of beta-lactamase inhibitor pharmacokinetics in the pharmacodynamics of inhibitor\u2013drug combinations: studies with piperacillin\u2013tazobactam and piperacillin\u2013sulbactam","volume":"41","author":"Lister","year":"1997","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib26","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1128\/JCM.35.10.2593-2597.1997","article-title":"Occurrence and detection of extended-spectrum \u03b2-lactamases in members of the family Enterobacteriaceae at a Veterans Medical Center: seek and you may find","volume":"35","author":"Coudron","year":"1997","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib27","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1128\/AAC.42.6.1459","article-title":"Ceftazidime and aztreonam resistance in Providencia stuartii: characterization of a natural TEM-derived extended spectrum beta-lactamase, TEM-60","volume":"42","author":"Franceschini","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib28","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1128\/AAC.35.9.1697","article-title":"More extended-spectrum \u03b2-lactamases","volume":"35","author":"Jacoby","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib29","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/ajcp\/84.4.496","article-title":"The cefoperazone\u2013sulbactam combination. In vitro qualities including beta-lactamase stability, antimicrobial activity, and interpretive criteria for disk diffusion tests","volume":"84","author":"Jones","year":"1985","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib30","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jac\/dkh140","article-title":"Post-antibiotic and post-beta-lactamase inhibitor effects of ceftazidime plus sulbactam on extended-spectrum beta-lactamase-producing Gram-negative bacteria","volume":"53","author":"Lavigne","year":"2004","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib31","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1093\/clinids\/24.3.498","article-title":"Sulbactam\/cefoperazone versus cefotaxime for the treatment of moderate-to-severe bacterial infections: results of a randomized, controlled clinical trial","volume":"24","author":"Li","year":"1997","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1179\/joc.1997.9.2.89","article-title":"Tazobactam\u2013piperacillin compared with sulbactam\u2013ampicillin, clavulanic acid\u2013ticarcillin, sulbactam\u2013cefoperazone, and piperacillin for activity against \u03b2-lactamase-producing bacteria isolated from patients with complicated urinary tract infections","volume":"9","author":"Nomura","year":"1997","journal-title":"J Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib33","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1128\/AAC.46.1.196-202.2002","article-title":"Occurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugs","volume":"46","author":"Spanu","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2006.02.017_bib34","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1128\/JCM.38.2.542-546.2000","article-title":"Detection of extended-spectrum \u03b2-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes","volume":"38","author":"Tzelepi","year":"2000","journal-title":"J Clin Microbiol"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906001452?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857906001452?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,16]],"date-time":"2020-04-16T07:51:23Z","timestamp":1587023483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857906001452"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,2]]}},"alternative-id":["S0924857906001452"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2006.02.017","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2]]}}}